We consider diagnosis of AD to be a confounding factor for the associations between tau biomarkers, neurodegeneration and cognition, and by adjusting for diagnosis, we believe that we may provide more robust estimates of the correlations. This evidence concerns the gene MAPT and Alzheimer disease.